stockrowTeleflex Incorporated
TFX Healthcare Medical Instruments & Supplies
Teleflex Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $2.0 billion, up 17.2% from fiscal 2024.
- Revenue
- +28.9%
- EPS
- −17.3%
- Free cash flow
- +220.1%
- Total debt
- +47.7%
Quarter to June 2026, against a year earlier
Follow TFX
Alert me
Teleflex Incorporated (TFX) EBITDA
Teleflex Incorporated's EBITDA for fiscal 2025 was $300.8M, up 12.0% from $268.6M in fiscal 2024. Over the twelve months to 30 June 2026 it was $256.2M. Over the past ten years it has ranged from $268.6M (fiscal 2024) to $778.8M (fiscal 2021); the current reading is higher than 18% of that period. Teleflex Incorporated ranks 20th of 47 Medical Instruments & Supplies companies by EBITDA.
EBITDA, annual
Embed this chart
Annual newest first
| Period | EBITDA | Change |
|---|---|---|
| FY2025 | $300.8M | 11.98% |
| FY2024 | $268.6M | (33.81%) |
| FY2023 | $405.8M | (44.74%) |
| FY2022 | $734.4M | (5.70%) |
| FY2021 | $778.8M | 18.95% |
| FY2020 | $654.8M | 2.38% |
| FY2019 | $639.5M | 19.23% |
| FY2018 | $536.4M | 0.71% |
| FY2017 | $532.6M | 18.94% |
| FY2016 | $447.8M | 1.49% |
Quarterly newest first
| Period | EBITDA | Change |
|---|---|---|
| Jun 2026 | $124.1M | 64.63% |
| Mar 2026 | $75.4M | — |
| Dec 2025 | −$75.3M | — |
| Sep 2025 | $132.0M | 2.39% |
| 42 more quarters | Free account |
Against its own ten years
EBITDA against peers
| Company | EBITDA |
|---|---|
| AVTR Avantor, Inc. compare | $913.6M |
| BLCO Bausch + Lomb Corporation compare | $801.0M |
| ATR AptarGroup, Inc. compare | $783.0M |
| NVST Envista Holdings Corporation compare | $428.9M |
| MMSI Merit Medical Systems, Inc. compare | $359.6M |
| ICUI ICU Medical, Inc. compare | $314.2M |
| TFX Teleflex Incorporated | $256.2M |
| MMED MiniMed Group, Inc. compare | −$8.0M |
| PLSE Pulse Biosciences, Inc compare | −$82.0M |
What EBITDA is
EBITDA shows what a company earns from its operations before interest, taxes and the non-cash charges for depreciation and amortization.
Reported line item
More on TFX
- Revenue
- Net income
- EPS (diluted)
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement